Analysis of the assortment and the availability of drugs, which are used in the schemes of antihelicobacter therapy at the pharmaceutical market of Ukraine
DOI:
https://doi.org/10.24959/uekj.17.10Keywords:
drugs for antihelicobacter therapy, pharmaceutical market, the rate of solvency adequacyAbstract
The prevalence and incidence of Helicobacter pylori-associated diseases inUkraineis high. Antihelicobacter therapy (AHT) is considered to be the main strategy for their treatment.
Aim. The analysis of the assortment of medicines used in the schemes for AHT at the pharmaceutical market of Ukraine, their economic availability for consumers and its dynamics in the years 2011-2015.
Materials. The assortment of proton pump inhibitors, antibacterial agents, bismuth preparations that are recommended for AHT in Ukraine were determined by using the data of the system «Pharmstandard» of the company «Morion», the economic availability – by using the rate of solvency adequacy.
Results. The drugs for AHT were presented in the 2011-2015 in a wide assortment at the pharmaceutical market ofUkraine, mainly of a foreign manufacture. The number of their international nonproprietary names did not differ in the period of study, but the number of their trade names decreased significantly in 2014-2015. Most drugs had a high and medium availability for the course of treatment for the average inhabitant of Ukraine 2011-2015. Over the years the availability of the majority of proton pump inhibitors and the antibacterial drugs were decreased for the population. For bismuth preparations the availability decrease was observed only in2014, in other years they were of a high availability for consumers.
Conclusions. Despite of the wide range of drugs for AHT inUkraine in 2011-2015 years, the availability of most of them was decreasing with years. This is due to the fact that the pace of the increase in prices for drugs exceeded the rate of the wage increase in a difficult socio-economic situation inUkraine.
References
Tkach, S. M. (2012). Suchasna hastroenterolohiia, 5 (67), 83–90.
Kharchenko, N. V., Lopukh, I. Ya., Korulia, I. A. et al. (2013). Hastroenterolohiia, 1 (47), 48–53.
Kolesnikova, O. V., Kozyrieva, T. E. (2014). Suchasna hastroenterolohiia, 6 (80), 137–141.
Palii, I. Н., Zaika, S. V., Piddubetska, A. P. (2013). Praktykuiuchyi likar, 3, 17–20.
Korniichuk, O. P., Shykula, R. H., Tymсhuk, I. V. et al. (2016). Biomedical and biosocial anthropology, 26, 169–172.
Bondar, G. V., Siedakov, I. Ye., Popovich, O. Ju. et al. (2013). Naukovyi visnyk Uzhhorodskoho universytetu. Medytsyna, 2 (47), 104–107.
Nakaz MOZ Ukrainy vid 13.06.2005 r. № 271 «Pro zatverdzhennia protokoliv nadannia medychnoi dopomohy za spetsialnistiu «Hastroenterolohiia». Klinichnyi protokol nadannia medychnoi dopomohy khvorym na khronichnyi hastryt». Available at: http://www.moz.gov.ua/ua/portal/dn_20050613_271.html
Nakaz MOZ Ukrainy vid 03.09.2014 r. № 613 «Pro zatverdzhennia ta vprovadzhennia medyko–tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry peptychnii vyraztsi shlunka ta dvanadtsiatypaloi
kyshky». Available at: http://www.moz.gov.ua/ua/portal/dn_20140903_0613.htm.
Malfertheiner, P., Megraud, F., Colm A O’Morain, Atherton J., T R Axon, A., Bazzoli, F. et al. (2012). Management of Helicobacter pylori infection – the Maastricht IV/ Florence Consensus Report. Gut, 61, 646–664. doi: 10.1136/gutjnl–2012–302084.
Yang, Jyh–Chin, Lu, Chien–Wei, Lin, Chun–Jung. (2014). Treatment of Helicobacter pylori infection: Current status and future concepts. World J. Gastroenterol., 20 (18), 5283–5293. doi: 10.3748/wjg.v20.i18.5283.
Skrypnyk, I. М., Osodlo, G. V. (2011). Suchasna hastroenterolohiia, 5 (61), 9–16.
Germaniuk, T. A., Dziubenko, S. P. (2012). Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 2 (9), 102–106.
Germaniuk, T. A, Volotska, N. A., Dziubenko, S. P. (2011). Farmatsevtychnyi zhurnal – Pharmaceutical Journal, 4, 10–17.
Slobodianiuk, N. N., Ivchenko, A. V. (2007). Provizor, 16, 8–11.
Kotvitska, A. A., Khodakivska, V. P. (2013). Farmakom, 1, 100–106.
Khodakivska, V. P. (2016). Sotsialno–ekonomichni pidkhody do optymizatsii farmatsevtychnoho zabezpechennia khvorykh na vyrazkovu khvorobu. Extended abstract of candidate’s thesis. Kharkiv, 26.
Fedosov, A. I., Kyslychenko, V. S., Volkova, A. V. (2015). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 6 (44), 90–94.
Tikhonov, O. I., Bogdan, N. S., Shpychak O. S. (2016). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 4 (48), 78–86.
Olkhova, I. V., Trokhimchuk, V. V. (2013). Aktualni pytannia farmatsevtychnoi i medychnoi nauky i praktyky, 2 (12), 114–116.
Systema doslidzhennia rynku likarskykh zasobiv «Farmstandart» kompanii «Morion». Available at: http:// www.pharmstandart.com.ua
Mnushko, Z. N., Trufan, S. V. (2002). Provizor, 21, 18–21.
Nemchenko, A. S., Fursa, L. I. (2016). Sotsialna farmatsiia v okhoroni zdorovia – Social pharmacy in health care, 2 (2), 59–67. doi: 10.24959/sphhcj.16.37
Yakovlieva, L. V., Perederiy, A. V. (2015). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 4 (42), 87–94.
Dovgun, S. S. (2012). Sovremennye problemy nauki i obrazovaniia - Modern problems of Science and Education, 2, 33–39.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
